ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,037Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 331

$954K Total Retail Price of All Prescriptions

Rank: 4 out of 331

1,066 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
1% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,066 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

3% of this provider’s 1,066 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

4% of this provider’s 21,764 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$30 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
TRAMADOL HCL-ACETAMINOPHEN 1,773 1,124 10 1 18
RANITIDINE HCL 1,508 1,067 2 4
SIMVASTATIN 1,371 970 3 1
GABAPENTIN 1,237 771 4 7
ENALAPRIL MALEATE 997 672 5 3
OMEPRAZOLE 930 626 6 5
AMLODIPINE BESYLATE 690 552 7 6
METFORMIN HCL 662 481 8 2
NABUMETONE 655 292 9 25
SYNTHROID 584 398 10 11
LEVOTHYROXINE SODIUM 572 445 11 9
GLIPIZIDE 490 374 12 19
ZOLPIDEM TARTRATE 490 260 12 22
DICLOFENAC POTASSIUM 483 344 14 32
PREDNISONE 482 315 15 68
AZITHROMYCIN 478 272 16 29
FENOFIBRATE 463 282 17 48
CIPROFLOXACIN HCL 451 310 18 36
FUROSEMIDE 440 339 19 15
METHYLPREDNISOLONE 427 246 20 101
HYDROCHLOROTHIAZIDE 426 316 21 10
METOPROLOL SUCCINATE 416 269 22 24
METOPROLOL TARTRATE 408 311 23 16
TAMSULOSIN HCL 370 300 24 34
ALENDRONATE SODIUM 358 280 25 17
PENTOXIFYLLINE 330 263 26 53
GLYBURIDE-METFORMIN HCL 283 252 R 27 54
DOXYCYCLINE HYCLATE 277 164 28 143
ATENOLOL 270 221 29 12
CARAFATE 223 176 30 170
SERTRALINE HCL 221 159 31 28
FLUCONAZOLE 220 125 32 211
CLOPIDOGREL 216 186 33 39
MECLIZINE HCL 215 198 34 51
LOSARTAN-HYDROCHLOROTHIAZIDE 213 153 35 14
THEOPHYLLINE ANHYDROUS 212 134 36 111
ETODOLAC 206 99 37 85
LOVASTATIN 205 151 38 55
LOSARTAN POTASSIUM 203 162 39 8
GLIMEPIRIDE 202 165 40 21
DIPYRIDAMOLE 201 137 R 41 72
PLAVIX 199 173 42 46
LEVOFLOXACIN 188 121 43 108
ATORVASTATIN CALCIUM 185 149 44 26
PANTOPRAZOLE SODIUM 183 82 45 41
AMLODIPINE BESYLATE-BENAZEPRIL 174 102 46 47
SULFAMETHOXAZOLE-TRIMETHOPRIM 170 100 47 107
DONEPEZIL HCL 169 159 48 38
ASPIRIN EC 166 135 49 27
LISINOPRIL 160 114 50 13
ISOSORBIDE DINITRATE 156 138 51 91
CETIRIZINE HCL 156 107 51 120
ORPHENADRINE CITRATE 154 37 R 53 122
TRAMADOL HCL 153 96 54 23
DIGOXIN 134 116 55 64
FAMOTIDINE 133 86 56 50
SINGULAIR 133 72 56 58
DICLOFENAC SODIUM 127 105 58 71
CARVEDILOL 126 109 59 33
SPIRONOLACTONE 125 93 60 126
ZETIA 124 88 61 84
HUMULIN 70-30 119 80 62 45
PAROXETINE HCL 118 96 63 80
AMITRIPTYLINE HCL 113 73 R 64 89
CILOSTAZOL 113 102 64 76
MEGESTROL ACETATE 109 106 R 66 98
HUMALOG MIX 75-25 109 39 66 128
WARFARIN SODIUM 107 103 68 66
VERAPAMIL ER 106 99 69 35
DICYCLOMINE HCL 104 27 70 167
CAPTOPRIL 103 103 71 42
GEMFIBROZIL 102 79 72 65
KETOCONAZOLE 100 38 73 96
ISOSORBIDE MONONITRATE ER 99 97 74 31
CLOTRIMAZOLE-BETAMETHASONE 99 56 74 43
AMOX TR-POTASSIUM CLAVULANATE 98 46 76 114
OXYCODONE-ACETAMINOPHEN 97 31 S2 77 78
CYCLOBENZAPRINE HCL 96 19 R 78 180
NAPROXEN SODIUM 96 56 78 116
ADVAIR DISKUS 93 49 80 92
MUPIROCIN 91 55 81 156
FLUTICASONE PROPIONATE 88 29 82 60
GLYBURIDE 88 88 R 82 56
PRAVASTATIN SODIUM 88 61 82 20
NYSTATIN-TRIAMCINOLONE 85 40 85 197
QUINAPRIL HCL 84 51 86 106
HUMULIN N 84 56 86 44
QUETIAPINE FUMARATE 80 53 88 129
LANTUS 80 54 88 40
FLUOXETINE HCL 80 48 88 102
LYRICA 80 30 88 97
CYMBALTA 75 39 92 113
INSULIN SYRINGE 72 43 93 37
MONTELUKAST SODIUM 71 34 94 180
CLONIDINE HCL 71 49 94 70
KETOROLAC TROMETHAMINE 69 28 R 96 292
GLIPIZIDE XL 68 62 97 88
SURE COMFORT 64 40 98 57
LANSOPRAZOLE 63 30 99 86
NAMENDA 63 58 99 63
HYDROXYZINE HCL 60 30 R 101 174
HYDRALAZINE HCL 60 21 101 137
NIFEDIPINE ER 60 53 101 104
SPIRIVA 59 44 104 155
DILTIAZEM HCL 59 54 104 125
DOXAZOSIN MESYLATE 59 55 104 30
GLIPIZIDE ER 58 49 107 121
GLYBURIDE MICRONIZED 57 50 R 108 67
DIOVAN 57 46 108 69
METOCLOPRAMIDE HCL 56 41 110 109
DILTIAZEM 24HR CD 55 39 111 211
CRESTOR 55 44 111 62
TOBRAMYCIN-DEXAMETHASONE 54 37 113 230
LOPERAMIDE 54 32 113 176
ALLOPURINOL 54 22 113 95
METRONIDAZOLE 52 32 116 332
IRBESARTAN 51 44 117 73
TRAZODONE HCL 50 40 118 135
FINASTERIDE 50 19 118 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 30, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.